Literature DB >> 8900471

Flow cytometric detection of intracellular platelet antigens.

P Sedlmayr1, B Grosshaupt, W Muntean.   

Abstract

Exocytosis following platelet activation leads to translocation of CD62P (P-selectin), CD63, and thrombospondin from cytoplasmic granules to the cell surface membrane, where these molecules, serving as activation markers, can be detected by flow cytometry. We report the detectability of these molecules preformed--prior to platelet activation--inside the cytoplasm of resting platelets. Two different methods are described, using either methanol or the Fix&Perm kit for cell membrane permeabilization. In addition, interleukin(IL-)1 alpha is shown to be present in platelet cytoplasm after methanol treatment but not after permeabilization using Fix&Perm. Whenever cell surface positivity for a specific marker coincides with intracellular presence, blocking of the surface membrane sites prior to membrane permeabilization is required in order to obtain fluorescence intensity attributable to cytoplasmic staining only. Our data demonstrate the feasibility of the methods described for the detection of intracellular platelet molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900471     DOI: 10.1002/(SICI)1097-0320(19960401)23:4<284::AID-CYTO4>3.0.CO;2-H

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  3 in total

1.  Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.

Authors:  Irene Lopez-Vilchez; Ulla Hedner; Carmen Altisent; Maribel Diaz-Ricart; Gines Escolar; Ana M Galan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

2.  Changes in platelet functional parameters and CD62 P expression in liver cirrhosis.

Authors:  G Xianghong; C Guanping; Y Fenghua; W Jiayin
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

3.  Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models.

Authors:  Lin Yu; Ying Lu; Yuqin Yao; Yu Liu; Yuxi Wang; Qinhuai Lai; Ruirui Zhang; Wenting Li; Ruixue Wang; Yuyin Fu; Yiran Tao; Shuli Yi; Lantu Gou; Ligong Chen; Jinliang Yang
Journal:  Oncotarget       Date:  2017-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.